Manhattan West Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.1M Buy
2,286
+113
+5% +$115K 0.41% 59
2025
Q4
$2.34M Sell
2,173
-46
-2% -$44K 0.48% 53
2025
Q3
$1.69M Buy
2,219
+5
+0.2% +$3.72K 0.36% 62
2025
Q2
$1.73M Buy
2,214
+87
+4% +$67.6K 0.4% 60
2025
Q1
$1.76M Buy
2,127
+423
+25% +$352K 0.45% 62
2024
Q4
$1.32M Buy
1,704
+91
+6% +$75.3K 0.36% 70
2024
Q3
$1.43M Buy
1,613
+56
+4% +$50.3K 0.37% 69
2024
Q2
$1.41M Sell
1,557
-208
-12% -$166K 0.38% 66
2024
Q1
$1.37M Buy
1,765
+1,209
+217% +$860K 0.33% 69
2023
Q4
$324K Sell
556
-30
-5% -$17.5K 0.09% 111
2023
Q3
$338K Buy
+586
New +$302K 0.1% 114

Other funds holding LLY

Manhattan West Asset Management's LLY Position: Q1 2026 in Review

Manhattan West Asset Management increased its Eli Lilly (LLY) stake by 5.2% in Q1 2026, buying an estimated $115K and bringing the position to 2,286 shares worth $2.1M. The position accounts for 0.41% of the portfolio, ranked #59.

Manhattan West Asset Management first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.34M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Manhattan West Asset Management held 2,286 shares of Eli Lilly worth $2.1M as of Q1 2026.
  • Manhattan West Asset Management bought 113 Eli Lilly shares in Q1 2026, an estimated $115K.
  • Eli Lilly made up 0.41% of Manhattan West Asset Management's portfolio in Q1 2026, its #59 holding.
  • Manhattan West Asset Management first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • Manhattan West Asset Management's Eli Lilly position peaked at $2.34M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Manhattan West Asset Management's 13F filing for Q1 2026, filed 14 May 2026.